68 related articles for article (PubMed ID: 6170758)
21. Allogeneic and associative recognition determinants of H-2 molecules.
Clark SS; Forman J
Transplant Proc; 1983 Dec; 15(4):2090-2. PubMed ID: 6200976
[TBL] [Abstract][Full Text] [Related]
22. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
23. Changes in the Ir gene controlled response phenotypes in mice of the Ap and Ak family of alleles expressing naturally occurring variant molecules.
Shaut DM; Wakeland EK; Maurer PH; Peck AB
J Immunol; 1984 Sep; 133(3):1410-6. PubMed ID: 6205082
[TBL] [Abstract][Full Text] [Related]
24. MHC-linked Ir gene control of T cell responses: GAT-specific proliferating T cells and helper T cells are elicited in nonresponder mice immunized with soluble GAT.
Gougeon ML; Theze J
J Immunol; 1983 Apr; 130(4):1521-6. PubMed ID: 6187811
[TBL] [Abstract][Full Text] [Related]
25. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
Oshima M; Atassi MZ
J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303
[TBL] [Abstract][Full Text] [Related]
26. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
Naiki M; Yoshida SH; Watanabe Y; Izui S; Ansari AA; Gershwin ME
J Autoimmun; 1993 Apr; 6(2):131-43. PubMed ID: 8388689
[TBL] [Abstract][Full Text] [Related]
27. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
Christadoss P; Lennon VA; Krco CJ; David CS
J Immunol; 1982 Mar; 128(3):1141-4. PubMed ID: 6799570
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the role of determinant selection in genetic control of the immune response to insulin in H-2b mice.
Thayer WP; Kraft JR; Tompkins SM; Moore JC; Jensen PE
J Immunol; 1999 Sep; 163(5):2549-54. PubMed ID: 10452992
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
[TBL] [Abstract][Full Text] [Related]
30. Insulin-specific tolerance induction. I. Abrogation of helper T cell activity is controlled by H-2-linked Ir genes.
Robbins PF; Thomas JW; Jensen PE; Kapp JA
J Immunol; 1984 Jan; 132(1):43-9. PubMed ID: 6197454
[TBL] [Abstract][Full Text] [Related]
31. T cell-independent responses to an Ir gene-controlled antigen. I. Characteristics of the immune response to insulin complexed to Brucella abortus.
Thomas JW; Bucy RP; Kapp JA
J Immunol; 1982 Jul; 129(1):6-10. PubMed ID: 6177760
[TBL] [Abstract][Full Text] [Related]
32. Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin.
Riley RL; Wilson LD; Germain RN; Benjamin DC
J Immunol; 1982 Oct; 129(4):1553-8. PubMed ID: 6180016
[TBL] [Abstract][Full Text] [Related]
33. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.
McKenzie IF; Morgan GM; Sandrin MS; Michaelides MM; Melvold RW; Kohn HI
J Exp Med; 1979 Dec; 150(6):1323-38. PubMed ID: 159937
[TBL] [Abstract][Full Text] [Related]
34. [Genetic control of the immune response to Streptococcus mutans, insulins and (T,G)-A--L in the rat].
Inomata T
Hokkaido Igaku Zasshi; 1983 Jul; 58(4):406-19. PubMed ID: 6195063
[TBL] [Abstract][Full Text] [Related]
35. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
[TBL] [Abstract][Full Text] [Related]
36. The isolation and functional characterization of autoimmune clones expressing inappropriate Ia.
Cronin PS; Sing AP; Glimcher LH; Kelley VE; Reinisch CL
J Immunol; 1984 Aug; 133(2):822-9. PubMed ID: 6610712
[TBL] [Abstract][Full Text] [Related]
37. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
38. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
39. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
40. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
von der Weid T; Beebe AM; Roopenian DC; Coffman RL
J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
